Published in Surgery on October 01, 1989
Oxidative stress is more important than acid in the pathogenesis of reflux oesophagitis in rats. Gut (2001) 1.90
Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux. Ann Surg (1992) 1.50
Role of intragastric and intraoesophageal alkalinisation in the genesis of complications in Barrett's columnar lined lower oesophagus. Gut (1993) 1.12
The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar lined oesophagus. Gut (1993) 1.11
Pathogenesis of columnar-lined esophagus. World J Gastroenterol (2006) 1.02
Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery. Ann Surg (1998) 1.00
Induction of oesophageal and forestomach carcinomas in rats by reflux of duodenal contents. Br J Cancer (1994) 1.00
NERD, GERD, and Barrett's esophagus: role of acid and non-acid reflux revisited with combined pH-impedance monitoring. Dig Dis Sci (2008) 0.97
24 hour ambulatory oesophageal pH monitoring in uncomplicated Barrett's oesophagus. Gut (1994) 0.96
Determinants of oesophageal 'alkaline' pH environment in controls and patients with gastro-oesophageal reflux disease. Gut (1993) 0.96
Optimizing acid suppression for treatment of acid-related diseases. Dig Dis Sci (1995) 0.96
A new physiologic approach for the surgical treatment of patients with Barrett's esophagus: technical considerations and results in 65 patients. Ann Surg (1997) 0.92
Analysis of ambulatory duodenogastroesophageal reflux monitoring. Dig Dis Sci (2000) 0.89
Proliferative activity in Barrett's esophagus before and after antireflux surgery. Ann Surg (2001) 0.89
Enteral vitamin B12 supplements reverse postgastrectomy B12 deficiency. Ann Surg (2000) 0.86
Effect of body mass index on adenocarcinoma of gastric cardia. World J Gastroenterol (2003) 0.86
Dysplasia and adenocarcinoma after classic antireflux surgery in patients with Barrett's esophagus: the need for long-term subjective and objective follow-up. Ann Surg (2002) 0.84
Bile acids but not acidic acids induce Barrett's esophagus. Int J Clin Exp Pathol (2015) 0.79
Barrett's esophagus: environmental influences in the progression of dysplasia. World J Surg (2003) 0.79
Role of bile acids, prostaglandins and COX inhibitors in chronic esophagitis in a mouse model. World J Gastroenterol (2006) 0.78
Early and late results of the acid suppression and duodenal diversion operation in patients with barrett's esophagus: analysis of 210 cases. World J Surg (2002) 0.77
Ambulatory long-term pH monitoring in pigs. Surg Endosc (2003) 0.77
Influence of obesity and bariatric surgery on gastric cancer. Cancer Biol Med (2016) 0.75
The knife or the pill in the long-term treatment of gastroesophageal reflux disease? Yale J Biol Med (1996) 0.75
Dynamic Microenvironment Induces Phenotypic Plasticity of Esophageal Cancer Cells Under Flow. Sci Rep (2016) 0.75
Radiological evaluation of the patency of duodenal-esophageal anastomosis during a long postoperative follow-up: effectiveness of an alkaline reflux model in rats. Clin Exp Gastroenterol (2011) 0.75
A new approach for the surgical treatment of Barrett's esophagus. Ann Surg (1997) 0.75
Technique, indications, and clinical use of 24 hour esophageal pH monitoring. J Thorac Cardiovasc Surg (1980) 4.60
Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients. Ann Surg (1986) 4.22
Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res (2001) 3.70
Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann Surg (1994) 3.09
Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol (1992) 2.96
Barrett's esophagus. Comparison of benign and malignant cases. Ann Surg (1983) 2.91
Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res (2000) 2.73
A contemporaneous comparison of hospital charges for laparoscopic and open Nissen fundoplication. Surg Endosc (1995) 2.59
Laparoscopic repair of large type III hiatal hernia: objective followup reveals high recurrence rate. J Am Coll Surg (2000) 2.53
Clinical and physiologic comparison of laparoscopic and open Nissen fundoplication. J Am Coll Surg (1995) 2.44
Ingested foreign bodies within the appendix: A 100-year review of the literature. Dig Dis (1999) 2.39
Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg (1994) 2.25
Development of the 24-hour intraesophageal pH monitoring composite scoring system. J Clin Gastroenterol (1986) 2.25
The lower esophageal sphincter in health and disease. Am J Surg (1988) 2.17
Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg (1995) 2.17
Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg (1999) 2.07
Normal 24-hr ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender. Dig Dis Sci (1992) 2.04
Five- to eight-year outcome of the first laparoscopic Nissen fundoplications. J Gastrointest Surg (2001) 2.03
Does duodenal juice reflux into the esophagus of patients with complicated GERD? Evaluation of a fiberoptic sensor for bilirubin. Am J Surg (1995) 1.98
Management of esophageal perforation. Am J Surg (1980) 1.90
Human gastric pacesetter potential. Site of origin, spread, and response to gastric transection and proximal gastric vagotomy. Am J Surg (1977) 1.88
The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication: prospective evaluation of 100 patients with "typical" symptoms. Ann Surg (1998) 1.81
Acute pancreatitis with hyperlipemia. Surgery (1971) 1.79
Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy. Arch Surg (1983) 1.75
Pathogenesis of esophagitis in patients with gastroesophageal reflux. Surgery (1980) 1.74
A more physiological alternative to total fundoplication for the surgical correction of resistant gastro-oesophageal reflux. Br J Surg (1991) 1.73
Polyps and carcinoma of the large bowel in the South African Bantu. Cancer (1970) 1.73
Esophageal function in patients with angina-type chest pain and normal coronary angiograms. Ann Surg (1982) 1.71
Clinical and in vitro analysis of determinants of gastroesophageal competence. A study of the principles of antireflux surgery. Am J Surg (1979) 1.69
Free radical scavengers prevent reflux esophagitis in rats. Dig Dis Sci (1995) 1.69
Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg (1994) 1.68
Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg (2001) 1.66
Length of the distal esophageal sphincter and competency of the cardia. Am J Surg (1986) 1.64
Surgery and the management of peripheral lung tumors adherent to the parietal pleura. J Thorac Cardiovasc Surg (1992) 1.64
Laparoscopic Nissen fundoplication: where do we stand? Surg Laparosc Endosc (1997) 1.64
Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg (2000) 1.63
En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma. J Thorac Cardiovasc Surg (2008) 1.61
Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy. Ann Surg (1999) 1.60
Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence. J Gastrointest Surg (2000) 1.59
Obturator hernia: a new technique for repair. J R Coll Surg Edinb (1998) 1.58
Esophagitis in Sprague-Dawley rats is mediated by free radicals. Dig Dis Sci (1995) 1.58
Computerized identification of pathologic duodenogastric reflux using 24-hour gastric pH monitoring. Ann Surg (1991) 1.58
Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg (1997) 1.58
Cystic and bullous lung disease. Ann Thorac Surg (1991) 1.55
Indications, benefits and outcome of laparoscopic Nissen fundoplication. Dig Dis (1997) 1.54
Immunosuppression in patients with Barrett's esophagus. Surgery (1992) 1.54
Potentially curable cancer of the esophagus. Cancer (1982) 1.53
Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids. J Gastrointest Surg (2000) 1.53
The evaluation of objective measurements of gastroesophageal reflux and their contribution to patient management. Surg Clin North Am (1976) 1.52
Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux. Ann Surg (1992) 1.50
Dysplasia in Barrett's esophagus: diagnosis, surveillance and treatment. Dig Dis (1996) 1.49
Talc pleurodesis: talc slurry versus thoracoscopic talc insufflation in a porcine model. Ann Thorac Surg (1996) 1.49
Diagnosis and management of synchronous lung cancers. J Thorac Cardiovasc Surg (1985) 1.48
Twenty-four-hour gastric luminal pH in normal subjects: influence of probe position, food, posture, and duodenogastric reflux. Am J Gastroenterol (1994) 1.48
Long-term outcome of antireflux surgery in patients with Barrett's esophagus. Ann Surg (2001) 1.48
The hypertensive lower esophageal sphincter. Am J Surg (1996) 1.45
The use of ultrasound to differentiate rectus sheath hematoma from other acute abdominal disorders. Surg Endosc (1999) 1.44
Laparoscopic paraesophageal hernia repair. Arch Surg (1997) 1.43
Surgical therapy in Barrett's esophagus. Ann Surg (1990) 1.43
Interaction of lower esophageal sphincter pressure and length of sphincter in the abdomen as determinants of gastroesophageal competence. Am J Surg (1982) 1.42
Drug-induced esophageal strictures. Ann Surg (1987) 1.40
Pharyngoesophageal dysfunctions. The role of cricopharyngeal myotomy. Arch Surg (1985) 1.39
Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg (2000) 1.39
Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats. Surgery (1992) 1.38
Current management of benign oesophageal strictures. J R Coll Surg Edinb (1989) 1.38
Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia. J Thorac Cardiovasc Surg (1993) 1.38
Canine gastric emptying of solids and liquids. Am J Physiol (1977) 1.37
Composition and concentration of bile acid reflux into the esophagus of patients with gastroesophageal reflux disease. Surgery (1997) 1.37
Elevated body mass disrupts the barrier to gastroesophageal reflux; discussion 1018-9. Arch Surg (2001) 1.37
Alkaline gastroesophageal reflux: assessment by ambulatory esophageal aspiration and pH monitoring. Am J Surg (1994) 1.35
Relationship of a hiatal hernia to the function of the body of the esophagus and the gastroesophageal junction. J Thorac Cardiovasc Surg (1981) 1.34
Management of ingested foreign bodies within the appendix: a case report with review of the literature. Am J Gastroenterol (1997) 1.33
High volume centers for esophagectomy: what is the number needed to achieve low postoperative mortality? Dis Esophagus (2004) 1.33
Midgut nonrotation in adults. An aggressive approach. Am J Surg (1975) 1.32
The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure. J Thorac Cardiovasc Surg (1999) 1.29
Gastroesophageal reflux in achalasia. When is reflux really reflux? Dig Dis Sci (1997) 1.28
A new technique for measurement of pharyngeal pH: normal values and discriminating pH threshold. J Gastrointest Surg (2009) 1.26
Duodenoesophageal reflux induces esophageal adenocarcinoma without exogenous carcinogen. J Gastrointest Surg (1999) 1.26